Chronic hepatitis B prognostic markers other than pre-treatment viral load predicted composite treatment outcome

Introduction: Chronic hepatitis B (CHB) is a globally common infectious disease. Its clinical course is complicated. In Southeast Asia, nucleos(t)ide analogues (NA) are commonly used drugs for CHB treatment. Composite treatment outcome has often been used in CHB clinical practice, but rarely predic...

Full description

Saved in:
Bibliographic Details
Main Authors: Myo Nyein Aung, Wattana Leowattana, Khine Nwe Win, Noppadon Tangpukdee, Sant Muangnoicharoen
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2013-07-01
Series:Journal of Infection in Developing Countries
Subjects:
Online Access:https://jidc.org/index.php/journal/article/view/2759
Tags: Add Tag
No Tags, Be the first to tag this record!